Analysis

High Court Plavix Ruling To Shrink, Scatter Mass Torts

Law360, New York (June 19, 2017, 10:24 PM EDT) -- The U.S. Supreme Court’s decision that almost 600 non-Californians can’t pursue claims in that state alleging that they were harmed by Bristol-Myers Squibb Co.’s blood thinner Plavix will likely reshape national mass tort litigation, as consumers will have fewer choices on where to file suit.

Almost unanimously, the Supreme Court found that California state courts don’t have jurisdiction over outsiders’ suits, reversing a decision by the state’s high court that given the drugmaker’s business ties to the state, California courts could exercise personal specific jurisdiction over their...
To view the full article, register now.